Piedmont Investment Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-18,396
| Closed | -$1.65M | – | 775 |
|
|
2020
Q1 | $1.65M | Buy |
18,396
+2,160
| +13% | +$194K | 0.07% | 232 |
|
|
2019
Q4 | $1.76M | Buy |
16,236
+650
| +4% | +$70.3K | 0.06% | 231 |
|
|
2019
Q3 | $1.53M | Buy |
15,586
+287
| +2% | +$28.1K | 0.06% | 237 |
|
|
2019
Q2 | $2M | Sell |
15,299
-1,170
| -7% | -$153K | 0.08% | 207 |
|
|
2019
Q1 | $2.23M | Buy |
16,469
+310
| +2% | +$41.9K | 0.09% | 202 |
|
|
2018
Q4 | $1.57M | Buy |
16,159
+1,047
| +7% | +$102K | 0.08% | 214 |
|
|
2018
Q3 | $2.1M | Buy |
15,112
+5,790
| +62% | +$805K | 0.09% | 200 |
|
|
2018
Q2 | $1.16M | Sell |
9,322
-22,944
| -71% | -$2.85M | 0.06% | 298 |
|
|
2018
Q1 | $3.6M | Sell |
32,266
-14,542
| -31% | -$1.62M | 0.1% | 217 |
|
|
2017
Q4 | $5.6M | Sell |
46,808
-154
| -0.3% | -$18.4K | 0.11% | 199 |
|
|
2017
Q3 | $6.59M | Buy |
46,962
+429
| +0.9% | +$60.2K | 0.14% | 186 |
|
|
2017
Q2 | $5.66M | Buy |
46,533
+446
| +1% | +$54.3K | 0.13% | 195 |
|
|
2017
Q1 | $5.59M | Buy |
46,087
+401
| +0.9% | +$48.6K | 0.12% | 205 |
|
|
2016
Q4 | $5.59M | Buy |
45,686
+1,003
| +2% | +$123K | 0.11% | 193 |
|
|
2016
Q3 | $5.48M | Sell |
44,683
-4,619
| -9% | -$566K | 0.12% | 191 |
|
|
2016
Q2 | $5.76M | Buy |
49,302
+914
| +2% | +$107K | 0.12% | 185 |
|
|
2016
Q1 | $6.74M | Buy |
48,388
+744
| +2% | +$104K | 0.14% | 158 |
|
|
2015
Q4 | $9.09M | Buy |
47,644
+421
| +0.9% | +$80.3K | 0.19% | 130 |
|
|
2015
Q3 | $7.39M | Buy |
47,223
+378
| +0.8% | +$59.1K | 0.17% | 144 |
|
|
2015
Q2 | $8.47M | Buy |
+46,845
| New | +$8.47M | 0.18% | 146 |
|